[{"model": "acmg_db.classificationquestion", "pk": 1, "fields": {"acmg_code": "PVS1", "order": 1, "text": "Null variant (nonsense, frameshift, canonical \u00b11 or 2 splice sites, initiation codon, single or multi-exon\r\ndeletion) in a gene where LOF is a known mechanism of disease.", "default_strength": "PV", "allowed_strength_change": true, "pathogenic_question": true, "category": "Variant type and gene-variant profile"}}, {"model": "acmg_db.classificationquestion", "pk": 2, "fields": {"acmg_code": "PS1", "order": 11, "text": "Same amino acid change as a previously established pathogenic variant regardless of nucleotide change.", "default_strength": "PS", "allowed_strength_change": true, "pathogenic_question": true, "category": "Review of literature and databases"}}, {"model": "acmg_db.classificationquestion", "pk": 3, "fields": {"acmg_code": "PS2", "order": 19, "text": "De novo (both maternity and paternity confirmed) in a patient with the disease and no family history.", "default_strength": "PS", "allowed_strength_change": true, "pathogenic_question": true, "category": "De novo variants"}}, {"model": "acmg_db.classificationquestion", "pk": 4, "fields": {"acmg_code": "PS3", "order": 14, "text": "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product.", "default_strength": "PS", "allowed_strength_change": true, "pathogenic_question": true, "category": "Functional studies"}}, {"model": "acmg_db.classificationquestion", "pk": 5, "fields": {"acmg_code": "PS4", "order": 6, "text": "The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls.", "default_strength": "PS", "allowed_strength_change": true, "pathogenic_question": true, "category": "Frequency data"}}, {"model": "acmg_db.classificationquestion", "pk": 6, "fields": {"acmg_code": "PM1", "order": 12, "text": "Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation.", "default_strength": "PM", "allowed_strength_change": true, "pathogenic_question": true, "category": "Review of literature and databases"}}, {"model": "acmg_db.classificationquestion", "pk": 7, "fields": {"acmg_code": "PM2", "order": 7, "text": "Absent from controls (or at extremely low frequency if recessive) (Table 6) in Exome Sequencing Project,\r\n1000 Genomes Project, or Exome Aggregation Consortium.", "default_strength": "PM", "allowed_strength_change": true, "pathogenic_question": true, "category": "Frequency data"}}, {"model": "acmg_db.classificationquestion", "pk": 8, "fields": {"acmg_code": "PM3", "order": 24, "text": "For recessive disorders, detected in trans with a pathogenic variant.", "default_strength": "PM", "allowed_strength_change": true, "pathogenic_question": true, "category": "Multiple variants identified in a patient"}}, {"model": "acmg_db.classificationquestion", "pk": 9, "fields": {"acmg_code": "PM4", "order": 2, "text": "Protein length changes as a result of in-frame deletions/insertions in a nonrepeat region or stop-loss variants.", "default_strength": "PM", "allowed_strength_change": true, "pathogenic_question": true, "category": "Variant type and gene-variant profile"}}, {"model": "acmg_db.classificationquestion", "pk": 10, "fields": {"acmg_code": "PM5", "order": 13, "text": "Missense change at an amino acid where a different missense change has previously been established as (likely) pathogenic.", "default_strength": "PM", "allowed_strength_change": true, "pathogenic_question": true, "category": "Review of literature and databases"}}, {"model": "acmg_db.classificationquestion", "pk": 11, "fields": {"acmg_code": "PM6", "order": 20, "text": "Assumed de novo, but without confirmation of paternity and maternity.", "default_strength": "PM", "allowed_strength_change": true, "pathogenic_question": true, "category": "De novo variants"}}, {"model": "acmg_db.classificationquestion", "pk": 12, "fields": {"acmg_code": "PP1", "order": 21, "text": "Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease.", "default_strength": "PP", "allowed_strength_change": true, "pathogenic_question": true, "category": "Phenotype and family history information"}}, {"model": "acmg_db.classificationquestion", "pk": 13, "fields": {"acmg_code": "PP2", "order": 3, "text": "Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease.", "default_strength": "PP", "allowed_strength_change": true, "pathogenic_question": true, "category": "Variant type and gene-variant profile"}}, {"model": "acmg_db.classificationquestion", "pk": 14, "fields": {"acmg_code": "PP3", "order": 16, "text": "Multiple lines of computational evidence support a deleterious effect on the gene or gene product\r\n(conservation, evolutionary, splicing impact, etc.).", "default_strength": "PP", "allowed_strength_change": true, "pathogenic_question": true, "category": "Computer predictions"}}, {"model": "acmg_db.classificationquestion", "pk": 15, "fields": {"acmg_code": "PP4", "order": 22, "text": "Patient\u2019s phenotype or family history is highly specific for a disease with a single genetic etiology.", "default_strength": "PP", "allowed_strength_change": true, "pathogenic_question": true, "category": "Phenotype and family history information"}}, {"model": "acmg_db.classificationquestion", "pk": 16, "fields": {"acmg_code": "BA1", "order": 8, "text": "Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium.", "default_strength": "BA", "allowed_strength_change": true, "pathogenic_question": false, "category": "Frequency data"}}, {"model": "acmg_db.classificationquestion", "pk": 17, "fields": {"acmg_code": "BS1", "order": 9, "text": "Allele frequency is greater than expected for disorder.", "default_strength": "BS", "allowed_strength_change": true, "pathogenic_question": false, "category": "Frequency data"}}, {"model": "acmg_db.classificationquestion", "pk": 18, "fields": {"acmg_code": "BS2", "order": 10, "text": "Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age.", "default_strength": "BS", "allowed_strength_change": true, "pathogenic_question": false, "category": "Frequency data"}}, {"model": "acmg_db.classificationquestion", "pk": 19, "fields": {"acmg_code": "BS3", "order": 15, "text": "Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing.", "default_strength": "BS", "allowed_strength_change": true, "pathogenic_question": false, "category": "Functional studies"}}, {"model": "acmg_db.classificationquestion", "pk": 20, "fields": {"acmg_code": "BS4", "order": 23, "text": "Lack of segregation in affected members of a family.", "default_strength": "BS", "allowed_strength_change": true, "pathogenic_question": false, "category": "Phenotype and family history information"}}, {"model": "acmg_db.classificationquestion", "pk": 21, "fields": {"acmg_code": "BP1", "order": 4, "text": "Missense variant in a gene for which primarily truncating variants are known to cause disease.", "default_strength": "BP", "allowed_strength_change": true, "pathogenic_question": false, "category": "Variant type and gene-variant profile"}}, {"model": "acmg_db.classificationquestion", "pk": 22, "fields": {"acmg_code": "BP2", "order": 25, "text": "Observed in trans with a pathogenic variant for a fully penetrant dominant gene/disorder or observed in cis with a pathogenic variant in any inheritance pattern.", "default_strength": "BP", "allowed_strength_change": true, "pathogenic_question": false, "category": "Multiple variants identified in a patient"}}, {"model": "acmg_db.classificationquestion", "pk": 23, "fields": {"acmg_code": "BP3", "order": 5, "text": "In-frame deletions/insertions in a repetitive region without a known function.", "default_strength": "BP", "allowed_strength_change": true, "pathogenic_question": false, "category": "Variant type and gene-variant profile"}}, {"model": "acmg_db.classificationquestion", "pk": 24, "fields": {"acmg_code": "BP4", "order": 17, "text": "Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.).", "default_strength": "BP", "allowed_strength_change": true, "pathogenic_question": false, "category": "Computer predictions"}}, {"model": "acmg_db.classificationquestion", "pk": 25, "fields": {"acmg_code": "BP7", "order": 18, "text": "A synonymous (silent) variant for which splicing prediction algorithms predict no impact to the splice consensus sequence nor the creation of a new splice site AND the nucleotide is not highly conserved", "default_strength": "BP", "allowed_strength_change": true, "pathogenic_question": false, "category": "Computer predictions"}}, {"model": "acmg_db.classificationquestion", "pk": 26, "fields": {"acmg_code": "BP5", "order": 26, "text": "Variant found in a case with an alternate molecular basis for disease.", "default_strength": "BP", "allowed_strength_change": true, "pathogenic_question": false, "category": "Multiple variants identified in a patient"}}]